Literature DB >> 7189923

[Effect of buformin and diphenylhydantoin on the life span, estrous function and spontaneous tumor incidence in rats].

V N Anisimov.   

Abstract

Chronic treatment of female rats with buformin (k mg/day per rat) is shown to decrease the body weight, to increase the average life span by 9% and to reduce the incidence of spontaneous tumors. The administration of diphenylhydantoin (7.5 mg/day per rat) would not change these parameters. The treatment of rats with buformin and diphenylhydantoin was also found to prolong their reproductive period and to reinitiate regular estrous cycles in persistent estrous rats.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7189923

Source DB:  PubMed          Journal:  Vopr Onkol        ISSN: 0507-3758


  14 in total

Review 1.  Calorie restriction: what recent results suggest for the future of ageing research.

Authors:  Daniel L Smith; Tim R Nagy; David B Allison
Journal:  Eur J Clin Invest       Date:  2010-05       Impact factor: 4.686

Review 2.  The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.

Authors:  Vladimir N Anisimov; Andrzej Bartke
Journal:  Crit Rev Oncol Hematol       Date:  2013-02-21       Impact factor: 6.312

Review 3.  Do metformin a real anticarcinogen? A critical reappraisal of experimental data.

Authors:  Vladimir N Anisimov
Journal:  Ann Transl Med       Date:  2014-06

4.  Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat.

Authors:  Zongjian Zhu; Weiqin Jiang; Matthew D Thompson; Dimas Echeverria; John N McGinley; Henry J Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2015-03-24

5.  Metformin supplementation and life span in Fischer-344 rats.

Authors:  Daniel L Smith; Calvin F Elam; Julie A Mattison; Mark A Lane; George S Roth; Donald K Ingram; David B Allison
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-03-19       Impact factor: 6.053

Review 6.  Metformin: do we finally have an anti-aging drug?

Authors:  Vladimir N Anisimov
Journal:  Cell Cycle       Date:  2013-10-24       Impact factor: 4.534

7.  Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice.

Authors:  Vladimir N Anisimov; Tatiana S Piskunova; Irina G Popovich; Mark A Zabezhinski; Margarita L Tyndyk; Peter A Egormin; Maria V Yurova; Svetlana V Rosenfeld; Anna V Semenchenko; Irina G Kovalenko; Tatiana E Poroshina; Lev M Berstein
Journal:  Aging (Albany NY)       Date:  2010-12       Impact factor: 5.682

Review 8.  Metformin for aging and cancer prevention.

Authors:  Vladimir N Anisimov
Journal:  Aging (Albany NY)       Date:  2010-11       Impact factor: 5.682

9.  If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice.

Authors:  Vladimir N Anisimov; Lev M Berstein; Irina G Popovich; Mark A Zabezhinski; Peter A Egormin; Tatiana S Piskunova; Anna V Semenchenko; Margarita L Tyndyk; Maria N Yurova; Irina G Kovalenko; Tatiana E Poroshina
Journal:  Aging (Albany NY)       Date:  2011-02       Impact factor: 5.682

10.  Metformin as an energy restriction mimetic agent for breast cancer prevention.

Authors:  Zongjian Zhu; Weiqin Jiang; Matthew D Thompson; John N McGinley; Henry J Thompson
Journal:  J Carcinog       Date:  2011-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.